Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD

Journal of the American Society of Nephrology

Volumn 15, Issue 11, 2004, Pages 2857-2867

  Reynolds, Joanne L ^a   Joannides, Alexis J ^a   Skepper, Jeremy N ^b   Mcnair, Rosamund ^a   Schurgers, Leon J ^c   Proudfoot, Diane ^a   Jahnen Dechent, Willi ^d   Weissberg, Peter L ^a   Shanahan, Catherine M ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b Multi Imaging Centre   (United Kingdom)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; FETUIN; OSTEOCALCIN; PHOSPHATE; WARFARIN;

APOPTOSIS; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CELL DEATH; CELL FUNCTION; CELL MEDIATED CYTOTOXICITY; CONCENTRATION RESPONSE; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KIDNEY FAILURE; MEMBRANE VESICLE; MINERALIZATION; MORBIDITY; PHOSPHATE BLOOD LEVEL; PHYSIOLOGY; PRECIPITATION; PRIORITY JOURNAL; PURIFICATION; SERUM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ADOLESCENT; ADULT; AGED; AORTA; BLOOD; CALCINOSIS; CHILD; CHRONIC KIDNEY FAILURE; DRUG POTENTIATION; EXTRACELLULAR FLUID; METABOLISM; MIDDLE AGED; OSMOLARITY; PRESCHOOL CHILD; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; AORTA; APOPTOSIS; BLOOD; CALCINOSIS; CALCIUM; CHILD; CHILD, PRESCHOOL; DRUG SYNERGISM; EXTRACELLULAR FLUID; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSMOLAR CONCENTRATION; PHOSPHATES; PRECIPITATION; VASCULAR DISEASES;

EID: 14544283020     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000141960.01035.28     Document Type: Article

References (39)

1. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938-942, 2001
2. Goodman WG: Vascular calcification in chronic renal failure. Lancet 2358: 1115-1116, 2001
3. Wilmer WA, Magro CM: Calciphylaxis: Emerging concepts in prevention, diagnosis, and treatment. Semin Dial 15: 172-186, 2002
4. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31: 607-617, 1998
5. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000
6. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME: Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: Evidence for smooth muscle cell-mediated vascular calcification. Circulation 100: 2168-2176, 1999
7. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL: Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91: 1800-1809, 1993
8. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386: 78-81, 1997
9. Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shanahan CM: Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 23: 489-494, 2003
10. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL: Apoptosis regulates human vascular calcification in vitro: Evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 87: 1055-1062, 2000
11. Wang W, Xu J, Kirsch T: Annexin-mediated Ca2+ influx regulates growth plate chondrocyte maturation and apoptosis. J Biol Chem 278: 3762-3769, 2003
12. Kim KM: Calcification of matrix vesicles in human aortic valve and aortic media. Fed Proc 35: 156-162, 1976
13. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K: Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61: 638-647, 2002
14. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87: E10-E17, 2000
15. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet 361: 827-833, 2003
16. Proudfoot D, Skepper JN, Shanahan CM, Weissberg PL: Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol 18: 379-388, 1998
17. Tintut Y, Parhami F, Bostrom K, Jackson SM, Demer LL: cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J Biol Chem 273: 7547-7553, 1998
18. Bennett MR, Evan GI, Schwartz SM: Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 95: 2266-2274, 1995
19. Wuthier RE, Chin JE, Hale JE, Register TC, Hale LV, Ishikawa Y: Isolation and characterization of calcium-accumulating matrix vesicles from chondrocytes of chicken epiphyseal growth plate cartilage in primary culture. J Biol Chem 260: 15972-15979, 1985
20. Hashimoto S, Ochs RL, Rosen F, Quach J, McCabe G, Solan J, Seegmiller JE, Terkeltaub R, Lotz M: Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci U S A 95: 3094-3099, 1998
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951
22. Kirsch T, Nah HD, Shapiro IM, Pacifici M: Regulated production of mineralization-competent matrix vesicles in hypertrophic chondrocytes. J Cell Biol 137: 1149-1160, 1997
23. Jahnen-Dechent W, Schinke T, Trindl A, Muller-Esterl W, Sablitzky F, Kaiser S, Blessing M: Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 272: 31496-31503, 1997
24. Braam LA, Dissel P, Gijsbers BL, Spronk HM, Hamulyak K, Soute BA, Debie W, Vermeer C: Assay for human matrix gla protein in serum: potential applications in the cardiovascular field. Arterioscler Thromb Vasc Biol 20: 1257-1261, 2000
25. Kockx MM, De Meyer GR, Muhring J, Jacob W, Bult H, Herman AG: Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 97: 2307-2315, 1998
26. Olszak IT, Poznansky MC, Evans RH, Olson D, Kos C, Pollak MR, Brown EM, Scadden DT: Extracellular calcium elicits a chemokinetic response from monocytes in vitro and in vivo. J Clin Invest 105: 1299-1305, 2000
27. Stehbens WE: Localization of experimental calcification in rabbit blood vessels with particular reference to hemodynamics. Angiology 39: 597-608, 1998
28. Hsu HH, Camacho NP: Isolation of calcifiable vesicles from human atherosclerotic aortas. Atherosclerosis 143: 353-362, 1999
29. Fleckenstein-Grun G, Thimm F, Czirfuzs A, Matyas S, Frey M: Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations. J Cardiovasc Pharmacol 24[Suppl 2]: S75-S84, 1994
30. Montessuit C, Bonjour JP, Caverzasio J: Expression and regulation of Na-dependent P(i) transport in matrix vesicles produced by osteoblast-like cells. J Bone Miner Res 10: 625-631, 1995
31. Farzaneh-Far A, Proudfoot D, Weissberg PL, Shanahan CM: Matrix gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor. Biochem Biophys Res Commun 277: 736-740, 2000
32. Price PA, Faus SA, Williamson MK: Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 18: 1400-1407, 1998
33. Chen NX, O'Neill KD, Duan D, Moe SM: Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 62: 1724-1731, 2002
34. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357-366, 2003
35. Block GA: Control of serum phosphorus: Implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis). Curr Opin Nephrol Hypertens 10: 741-747, 2001
36. Nolan CR, Qunibi WY: Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients. Curr Opin Nephrol Hypertens 12: 373-379, 2003
37. Cice G, Di Benedetto A, D'Andrea A, D'Isa S, Ferrara L, Russo PE, Iacono A, Calabro R: Sustained-release diltiazem reduces myocardial ischemic episodes in end-stage renal disease: A double-blind, randomized, crossover, placebo-controlled trial. J Am Soc Nephrol 14: 1006-1111, 2003
38. Kestenbaum B, Gillen DL, Sherrard DJ, Seliger S, Ball A, Stehman-Breen C: Calcium channel blocker use and mortality among patients with end-stage renal disease. Kidney Int 61: 2157-2164, 2002
39. Motro M, Shemesh J: Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. Hypertension 37: 1410-1413, 2001